Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl
The study aims to enrol about 150 patients across multiple sites.
A leading resource for the Pharmaceutical industry since 2002
The study aims to enrol about 150 patients across multiple sites.